サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1753844

一般用医薬品（OTC）の世界市場：2034年までの機会と戦略

Over The Counter (OTC) Drugs Global Market Opportunities And Strategies To 2034

出版日
ページ情報
英文 373 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.06円
一般用医薬品（OTC）の世界市場：2034年までの機会と戦略
出版日: 2025年06月20日
発行: The Business Research Company
ページ情報: 英文 373 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の一般用医薬品（OTC）市場は2019年に1,259億654万米ドルと評価され、2024年までCAGR4.00％以上で成長しました。

研究開発投資の増加

研究開発への投資の増加は、歴史的な期間における一般用医薬品（OTC）市場の成長に貢献しました。研究開発（R&D）への投資の増加は、セルフケア治療の技術革新を促進することにより、一般用医薬品（OTC）の成長を促進します。この投資により、より効果的で安全性の高い標的製剤の開発、ドラッグデリバリー方法の改善、規制遵守の強化が行われています。さらに、研究開発はブランドの差別化を促進し、市場の競争力を強化し、科学的裏付けのある先進的なOTC製品で消費者を魅了しています。例えば、ルクセンブルクに本部を置く欧州連合（EU）の統計局ユーロスタットによると、2023年12月、EUの研究開発（R&D）に対する支出は2022年に3,520億ユーロ（3,844億2,000万米ドル）に増加し、前年の3,310億ユーロ（3,614億8,000万米ドル）から6.34％増となりました。このため、研究開発投資の増加が一般用医薬品（OTC）市場の成長を牽引しました。

目次

第1章 エグゼクティブサマリー

    • 一般用医薬品（OTC）-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • 一般用医薬品（OTC）市場定義とセグメンテーション
  • 市場セグメンテーション：タイプ別
    • 咳、風邪、インフルエンザ対策製品
    • 鎮痛剤
    • 皮膚科製品
    • 胃腸薬
    • ビタミン、ミネラル、サプリメント（VMS）
    • 減量またはダイエット製品
    • 眼科用製品
    • 睡眠補助剤
    • その他の製品タイプ
  • 市場セグメンテーション：製剤タイプ別
    • 錠剤
    • 液体
    • 軟膏
    • スプレー
    • その他の製剤タイプ
  • 市場セグメンテーション：流通チャネル別
    • 病院薬局
    • 小売薬局
    • オンライン薬局
    • その他の流通チャンネル
  • 市場セグメンテーション：エンドユーザー別
    • 専門クリニック
    • ホームケア
    • 病院
    • その他のエンドユーザー

第7章 主要な市場動向

  • 眼アレルギー症状を緩和する生物学的同等性点眼液の開発
  • 勃起不全治療のための革新的な速効性OTCジェル
  • オピオイド過剰摂取対策のための手頃な価格の鼻腔スプレー発売
  • 画期的な市販避妊薬がより多くの人に届くように
  • 食べ過ぎや飲み過ぎによる下痢を抑える革新的な市販薬

第8章 一般用医薬品（OTC）の成長分析と戦略分析フレームワーク

  • 世界の一般用医薬品（OTC）に関するPESTEL分析（政治、社会、技術、環境、法的要因）
    • 政治的
    • 経済
    • 社会
    • 技術的
    • 環境
    • 法律上
  • エンドユーザー（B2B）の分析
    • 専門クリニック
    • ホームケア
    • 病院
    • その他のエンドユーザー
  • 一般用医薬品（OTC）市場：成長率分析
  • 市場成長実績, 2019-2024
    • 市場促進要因2019年～2024年
    • 市場抑制要因2019-2024年
  • 市場成長予測, 2024-2029, 2034F
    • 市場促進要因2024年～2029年
    • 市場抑制要因2024年～2029年
  • 成長予測の貢献要因
    • 量的成長の貢献者
    • 促進要因
    • 抑制要因
  • 一般用医薬品（OTC）の有効市場規模（TAM）

第9章 一般用医薬品（OTC）市場：セグメンテーション

  • 一般用医薬品（OTC）市場：タイプ別、実績と予測, 2019-2024, 2029F, 2034F
  • 一般用医薬品（OTC）市場：製剤タイプ別、実績と予測, 2019-2024, 2029F, 2034F
  • 一般用医薬品（OTC）市場：流通チャネル別、実績と予測, 2019-2024, 2029F, 2034F
  • 一般用医薬品（OTC）市場：エンドユーザー別、実績と予測, 2019-2024, 2029F, 2034F
  • 一般用医薬品（OTC）市場、咳、風邪、インフルエンザ対策製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2029F, 2034F
  • 一般用医薬品（OTC）市場、鎮痛剤によるサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2029F, 2034F
  • 一般用医薬品（OTC）市場、皮膚科製品によるサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2029F, 2034F
  • 一般用医薬品（OTC）市場、胃腸薬によるサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2029F, 2034F
  • 一般用医薬品（OTC）市場、ビタミン、ミネラル、サプリメント（VMS）によるサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2029F, 2034F
  • 一般用医薬品（OTC）市場、減量またはダイエット製品によるサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2029F, 2034F
  • 一般用医薬品（OTC）市場、眼科用製品によるサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2029F, 2034F
  • 一般用医薬品（OTC）市場、睡眠補助剤によるサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2029F, 2034F
  • 一般用医薬品（OTC）市場、その他の製剤タイプによるサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2029F, 2034F

第10章 一般用医薬品（OTC）市場：地域・国別分析

  • 一般用医薬品（OTC）市場：地域別、実績と予測, 2019-2024, 2029F, 2034F
  • 一般用医薬品（OTC）市場：国別、実績と予測, 2019-2024, 2029F, 2034F

第11章 アジア太平洋市場

第12章 西欧市場

第13章 東欧市場

第14章 北米市場

第15章 南米市場

第16章 中東市場

第17章 アフリカ市場

第18章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Bayer AG
  • Johnson & Johnson
  • GlaxoSmithKline PLC
  • Reckitt Benckiser Group PLC
  • Sanofi S.A.

第19章 その他の大手企業と革新的企業

  • Perrigo Company plc
  • Haleon plc
  • Teva Pharmaceutical Industries Ltd
  • Dr. Reddy's Laboratories
  • Cipla Ltd.
  • Sun Pharmaceutical Industries Ltd
  • Amneal Pharmaceuticals Inc.
  • Abbott Laboratories
  • Boehringer Ingelheim International GmbH
  • Glenmark Therapeutics Ltd.
  • Alkem Laboratories Ltd.
  • Sonoma Pharmaceuticals Inc.
  • Takeda Pharmaceutical Company Ltd
  • Viatris（Mylan NV）
  • AFT Pharmaceuticals Ltd.

第20章 競合ベンチマーキング

第21章 競合ダッシュボード

第22章 主要な合併と買収

  • Cooper Consumer Health Acquired Viatris Inc.
  • Avista Healthcare Partners Acquired Trillium Healthcare Products
  • Cipla South Africa Acquired Actor Pharma（Pty）Ltd.
  • Glenmark Pharmaceuticals Inc. Acquired Wockhardt USA Inc.

第23章 一般用医薬品（OTC）の最近の動向

  • 便秘の需要増加を狙った市販下剤の新製品
  • ビッグデータを活用して市販薬へのスムーズな移行を実現
  • 新しい市販サプリメントで母親の健康と乳児の開発を促進

第24章 機会と戦略

  • 一般用医薬品（OTC）市場2029：新たな機会を提供する国
  • 一般用医薬品（OTC）市場2029：新たな機会を提供するセグメント
  • 一般用医薬品（OTC）市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第25章 一般用医薬品（OTC）市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第26章 付録

    • 対象地域
    • 市場データソース
    • 調査手法
    • 通貨
    • ビジネス調査カンパニー
    • 著作権と免責事項
目次
Product Code: o&s1657

Over-the-counter (OTC) drugs are medications available for purchase without a prescription from a healthcare professional. They are designed for self-care, allowing individuals to manage common health issues such as headaches, colds, allergies and digestive problems.

The over the counter (OTC) drugs market consists of sales by entities (organizations, sole traders and partnerships) of over the counter (OTC) drugs that are typically used when symptoms are mild to moderate and do not require a doctor's intervention. OTC drugs often serve as the first line of treatment for minor ailments and can act as substitutes for prescription medications in certain situations. They are widely used across various settings, including homes, workplaces and while traveling, providing convenient relief from everyday health concerns.

The global over the counter (OTC) drugs market was valued at $125,906.54 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 4.00%.

Increasing Investment in Research And Development

The increasing investment in research and development contributed to the growth of the over-the-counter (OTC) drugs market in the historic period. The increasing investment in research and development (R&D) drives the growth of the over-the-counter (OTC) drug by driving innovation in self-care treatments. This investment has led to the development of more effective, safer and targeted formulations, improved drug delivery methods and enhanced regulatory compliance. Additionally, R&D fosters brand differentiation and strengthens market competitiveness, attracting consumers with advanced, science-backed OTC products. For instance, in December 2023, according to Eurostat, a Luxembourg-based statistical office of the European Union, the EU's expenditure on research and development (R&D) increased to €352 billion ($384.42 billion) in 2022, marking a 6.34% rise from €331 billion ($361.48) in the previous year. Therefore, increasing investment in research and development drove the growth of the over-the-counter (OTC) drugs market.

Development of Bioequivalent Ophthalmic Solution to Provide Eye Allergy Relief

Major companies operating in the over-the-counter (OTC) drugs market are focusing on the development of bioequivalent ophthalmic solutions to provide eye allergy relief. It offers the same therapeutic benefits at a potentially more competitive price, presenting an opportunity to drive revenue growth, expand its ophthalmic portfolio and solidify its position in the OTC pharmaceutical market. For instance, in March 2025, Glenmark Pharmaceuticals Inc., a US-based pharmaceutical company, received final approval from the U.S. Food and Drug Administration (FDA) for its olopatadine hydrochloride ophthalmic solution USP, 0.2% (OTC). This product is recognized as bioequivalent to Alcon Laboratories' Pataday Once Daily Relief Ophthalmic Solution, 0.2% (OTC). Distribution in the U.S. will be managed by Glenmark Therapeutics Inc., USA. With the Pataday market generating approximately $50.7 million in annual sales, this approval presents a strategic growth opportunity for Glenmark to strengthen its ophthalmic portfolio and expand its presence in the over-the-counter eye care segment.

The global over the counter (OTC) drugs markets is fairly fragmented, with large number of players operating in the market. The top 10 competitors in the market made up 14.11% of the total market in 2023.

Over The Counter (OTC) Drugs Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global over the counter (OTC) drugs market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for over the counter (OTC) drugs? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The over the counter (OTC) drugs market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider over the counter (OTC) drugs market; and compares it with other markets.

The report covers the following chapters

  • Introduction And Market Characteristics:- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by formulation type, by distribution channel and by end user.
  • Key Trends:- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis:- Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Regional And Country Analysis:- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation:- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by formulation type, by distribution channel and by end user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth:- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape:- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies:- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking:- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard:- Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions:- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Recent Developments:- Information on recent developments in the market covered in the report.
  • Market Opportunities And Strategies:- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets
  • Conclusions And Recommendations:- This section includes recommendations for over-the-counter (OTC) drugs market providers in terms of product/service offerings geographic expansion, marketing strategies and target groups
  • Appendix:- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Type: Cough, Cold And Flu Products; Analgesics; Dermatology Products; Gastrointestinal Products; Vitamins, Mineral And Supplements (VMS); Weight Loss Or Dietary Products; Ophthalmic Products; Sleeping Aids; Other Product Types
  • 2) By Formulation Type: Tablets; Liquids; Ointments; Sprays; Other Formulation Types
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Channels
  • 4) By End User: Specialty Clinics; Homecare; Hospitals; Other End Users
  • Companies Mentioned: Bayer AG; Johnson & Johnson; GlaxoSmithKline PLC; Reckitt Benckiser Group PLC; Sanofi S.A.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; over the counter (OTC) drugs indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

    • 1.1.1 Over The Counter (OTC) Drugs - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Over The Counter (OTC) Drugs Market Definition And Segmentations
  • 6.4 Market Segmentation By Type
    • 6.4.1 Cough, Cold and Flu Products
    • 6.4.2 Analgesics
    • 6.4.3 Dermatology Products
    • 6.4.4 Gastrointestinal Products
    • 6.4.5 Vitamins, Minerals and Supplements (VMS)
    • 6.4.6 Weight Loss or Dietary Products
    • 6.4.7 Ophthalmic Products
    • 6.4.8 Sleeping Aids
    • 6.4.9 Other Product Types
  • 6.5 Market Segmentation By Formulation Type
    • 6.5.1 Tablets
    • 6.5.2 Liquids
    • 6.5.3 Ointments
    • 6.5.4 Sprays
    • 6.5.5 Other Formulation Types
  • 6.6 Market Segmentation By Distribution Channel
    • 6.6.1 Hospital Pharmacies
    • 6.6.2 Retail Pharmacies
    • 6.6.3 Online Pharmacies
    • 6.6.4 Other Channels
  • 6.7 Market Segmentation By End User
    • 6.7.1 Specialty Clinics
    • 6.7.2 Homecare
    • 6.7.3 Hospitals
    • 6.7.4 Other End Users

7 Major Market Trends

  • 7.1 Development of Bioequivalent Ophthalmic Solution to Provide Eye Allergy Relief
  • 7.2 Innovative Fast-Acting OTC Gels For Erectile Dysfunction Treatment
  • 7.3 Launch of Affordable Nasal Spray to Combat Opioid Overdoses
  • 7.4 Groundbreaking Over-the-Counter Birth Control Pill Offers Greater Access
  • 7.5 Innovative OTC Drugs Targeting Diarrhea From Overeating And Overdrinking

8 Over The Counter (OTC) Drugs Growth Analysis And Strategic Analysis Framework

  • 8.1 Global Over The Counter (OTC) Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
    • 8.1.1 Political
    • 8.1.2 Economic
    • 8.1.3 Social
    • 8.1.4 Technological
    • 8.1.5 Environmental
    • 8.1.6 Legal
  • 8.2 Analysis Of End User (B2B)
    • 8.2.1 Specialty Clinics
    • 8.2.2 Homecare
    • 8.2.3 Hospitals
    • 8.2.4 Other End Users
  • 8.3 Over The Counter (OTC) Drugs Market Growth Rate Analysis
  • 8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
    • 8.4.1 Market Drivers 2019 - 2024
    • 8.4.2 Market Restraints 2019- 2024
  • 8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
    • 8.5.1 Market Drivers 2024 - 2029
    • 8.5.2 Market Restraints 2024 - 2029
  • 8.6 Forecast Growth Contributors/Factors
    • 8.6.1 Quantitative Growth Contributors
    • 8.6.2 Drivers
    • 8.6.3 Restraints
  • 8.7 Over The Counter (OTC) Drugs Total Addressable Market (TAM)

9 Over The Counter (OTC) Drugs Market Segmentation

  • 9.1 Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.2 Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.3 Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.4 Over The Counter (OTC) Drugs Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.5 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Cough, Cold, And Flu Products, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.6 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Analgesics, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.7 Over The Counter (OTC) Drugs Market, Sub-Segmentation Of Dermatology Products, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.8 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Gastrointestinal Products, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.9 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Vitamins, Mineral, And Supplements (VMS), By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.10 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Weight Loss Or Dietary Products, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.11 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Ophthalmic Products, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.12 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Sleeping Aids, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.13 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Other Product Types, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Over The Counter (OTC) Drugs Market, Regional and Country Analysis

  • 10.1 Over The Counter (OTC) Drugs Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.2 Over The Counter (OTC) Drugs Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

  • 11.1 Summary
  • 11.2 Market Overview
    • 11.2.1 Region Information
    • 11.2.2 Market Information
    • 11.2.3 Background Information
    • 11.2.4 Government Initiatives
    • 11.2.5 Regulations
    • 11.2.6 Regulatory Bodies
    • 11.2.7 Major Associations
    • 11.2.8 Taxes Levied
    • 11.2.9 Corporate Tax Structure
    • 11.2.10 Investments
    • 11.2.11 Major Companies
  • 11.3 Asia-Pacific Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.4 Asia-Pacific Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.5 Asia-Pacific Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.6 Asia-Pacific Over The Counter (OTC) Drugs Market: Country Analysis
  • 11.7 China Market
  • 11.8 Summary
  • 11.9 Market Overview
    • 11.9.1 Country Information
    • 11.9.2 Market Information
    • 11.9.3 Background Information
    • 11.9.4 Government Initiatives
    • 11.9.5 Regulations
    • 11.9.6 Regulatory Bodies
    • 11.9.7 Major Associations
    • 11.9.8 Taxes Levied
    • 11.9.9 Corporate Tax Structure
    • 11.9.10 Investments
    • 11.9.11 Major Companies
  • 11.10 China Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.11 China Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.12 China Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.13 India Market
  • 11.14 India Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.15 India Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.16 India Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.17 Japan Market
  • 11.18 Summary
  • 11.19 Market Overview
    • 11.19.1 Country Information
    • 11.19.2 Market Information
    • 11.19.3 Background Information
    • 11.19.4 Government Initiatives
    • 11.19.5 Regulations
    • 11.19.6 Regulatory Bodies
    • 11.19.7 Major Associations
    • 11.19.8 Taxes Levied
    • 11.19.9 Corporate Tax Structure
    • 11.19.10 Investments
    • 11.19.11 Major Companies
  • 11.20 Japan Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.21 Japan Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.22 Japan Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.23 Australia Market
  • 11.24 Australia Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.25 Australia Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.26 Australia Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.27 Indonesia Market
  • 11.28 Indonesia Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.29 Indonesia Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.30 Indonesia Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.31 South Korea Market
  • 11.32 Summary
  • 11.33 Market Overview
    • 11.33.1 Country Information
    • 11.33.2 Market Information
    • 11.33.3 Background Information
    • 11.33.4 Government Initiatives
    • 11.33.5 Regulations
    • 11.33.6 Regulatory Bodies
    • 11.33.7 Major Associations
    • 11.33.8 Taxes Levied
    • 11.33.9 Corporate Tax Structure
    • 11.33.10 Investments
    • 11.33.11 Major Companies
  • 11.34 South Korea Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.35 South Korea Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.36 South Korea Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate tax structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Western Europe Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.4 Western Europe Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.5 Western Europe Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.6 UK Market
  • 12.7 UK Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.8 UK Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.9 UK Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.10 Germany Market
  • 12.11 Germany Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.12 Germany Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.13 Germany Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.14 France Market
  • 12.15 France Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.16 France Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.17 France Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.18 Italy Market
  • 12.19 Italy Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.20 Italy Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.21 Italy Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.22 Spain Market
  • 12.23 Spain Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.24 Spain Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.25 Spain Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Investments
    • 13.2.11 Major companies
  • 13.3 Eastern Europe Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.4 Eastern Europe Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.5 Eastern Europe Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.6 Russia Market
  • 13.7 Russia Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.8 Russia Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.9 Russia Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Investments
    • 14.2.11 Major Companies
  • 14.3 North America Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.4 North America Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.5 North America Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.6 USA Market
  • 14.7 Summary
  • 14.8 Market Overview
    • 14.8.1 Country Information
    • 14.8.2 Market Information
    • 14.8.3 Background Information
    • 14.8.4 Government Initiatives
    • 14.8.5 Regulations
    • 14.8.6 Regulatory Bodies
    • 14.8.7 Major Associations
    • 14.8.8 Taxes Levied
    • 14.8.9 Corporate Tax Structure
    • 14.8.10 Investments
    • 14.8.11 Major Companies
  • 14.9 USA Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.10 USA Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.11 USA Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.12 Canada Market
  • 14.13 Summary
  • 14.14 Market Overview
    • 14.14.1 Country Information
    • 14.14.2 Market Information
    • 14.14.3 Background Information
    • 14.14.4 Government Initiatives
    • 14.14.5 Regulations
    • 14.14.6 Regulatory Bodies
    • 14.14.7 Major Associations
    • 14.14.8 Taxes Levied
    • 14.14.9 Corporate Tax Structure
    • 14.14.10 Investments
    • 14.14.11 Major Companies
  • 14.15 Canada Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.16 Canada Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.17 Canada Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 South America Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.4 South America Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.5 South America Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.6 Brazil Market
  • 15.7 Brazil Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.8 Brazil Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.9 Brazil Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investments
    • 16.2.11 Major Companies
  • 16.3 Middle East Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.4 Middle East Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.5 Middle East Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Africa Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.4 Africa Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.5 Africa Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

  • 18.1 Company Profiles
  • 18.2 Bayer AG
    • 18.2.1 Company Overview
    • 18.2.2 Products And Services
    • 18.2.3 Business Strategy
    • 18.2.4 Financial Overview
  • 18.3 Johnson & Johnson
    • 18.3.1 Company Overview
    • 18.3.2 Products And Services
    • 18.3.3 Financial Overview
  • 18.4 GlaxoSmithKline PLC
    • 18.4.1 Company Overview
    • 18.4.2 Products And Services
    • 18.4.3 Financial Overview
  • 18.5 Reckitt Benckiser Group PLC
    • 18.5.1 Company Overview
    • 18.5.2 Products And Services
    • 18.5.3 Business Strategy
    • 18.5.4 Financial Overview
  • 18.6 Sanofi S.A.
    • 18.6.1 Company Overview
    • 18.6.2 Products And Services
    • 18.6.3 Financial Overview

19 Other Major And Innovative Companies

  • 19.1 Perrigo Company plc
    • 19.1.1 Company Overview
    • 19.1.2 Products And Services
  • 19.2 Haleon plc
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
  • 19.3 Teva Pharmaceutical Industries Ltd
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
  • 19.4 Dr. Reddy's Laboratories
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
  • 19.5 Cipla Ltd.
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
  • 19.6 Sun Pharmaceutical Industries Ltd
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
  • 19.7 Amneal Pharmaceuticals Inc.
    • 19.7.1 Company Overview
    • 19.7.2 products And Services
  • 19.8 Abbott Laboratories
    • 19.8.1 Company Overview
    • 19.8.2 Products And Services
  • 19.9 Boehringer Ingelheim International GmbH
    • 19.9.1 Company Overview
    • 19.9.2 Products And Services
  • 19.10 Glenmark Therapeutics Ltd.
    • 19.10.1 Company Overview
    • 19.10.2 Products And Services
  • 19.11 Alkem Laboratories Ltd.
    • 19.11.1 Company Overview
    • 19.11.2 Products And Services
  • 19.12 Sonoma Pharmaceuticals Inc.
    • 19.12.1 Company Overview
    • 19.12.2 Products And Services
  • 19.13 Takeda Pharmaceutical Company Ltd
    • 19.13.1 Company Overview
    • 19.13.2 Products And Services
  • 19.14 Viatris (Mylan NV)
    • 19.14.1 Company Overview
    • 19.14.2 Products And Services
  • 19.15 AFT Pharmaceuticals Ltd.
    • 19.15.1 Company Overview
    • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Cooper Consumer Health Acquired Viatris Inc.
  • 22.2 Avista Healthcare Partners Acquired Trillium Healthcare Products
  • 22.3 Cipla South Africa Acquired Actor Pharma (Pty) Ltd.
  • 22.4 Glenmark Pharmaceuticals Inc. Acquired Wockhardt USA Inc.

23 Recent Developments in Over The Counter (OTC) Drugs

  • 23.1 New Over-the-Counter Laxative Targets Growing Constipation Demand
  • 23.2 Leveraging Big Data for Seamless Transition to Over-the-Counter Medications
  • 23.3 Enhancing Maternal Health and Infant Development with a New Over-the-Counter Supplement

24 Opportunities And Strategies

  • 24.1 Over The Counter (OTC) Drugs Market In 2029 - Countries Offering Most New Opportunities
  • 24.2 Over The Counter (OTC) Drugs Market In 2029 - Segments Offering Most New Opportunities
  • 24.3 Over The Counter (OTC) Drugs Market In 2029 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Over The Counter (OTC) Drugs Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

    • 26.1.1 Geographies Covered
    • 26.1.2 Market Data Sources
    • 26.1.3 Research Methodology
    • 26.1.4 Currencies
    • 26.1.5 The Business Research Company
    • 26.1.6 Copyright and Disclaimer